Phase II Trial of Erlotinib in Advanced Pancreatic Cancer
Clinical trial NCT00497224 · COMPLETED
Trial details
- NCT number
- NCT00497224
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2008-12-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.